We’ve gotten quite good at turning back the clocks lately, but we’re missing a vital point: that clock isn't just a timer. It’s a survival log.

When a pilot study shows a three-year drop in epigenetic age through plasma dilution or partial reprogramming, there’s plenty of reason to celebrate. But we’ve got to ask what we're actually scrubbing away. We tend to view the aging methylome as a pile of cellular junk, yet much of what looks like "decay" is actually trained immunity. It’s a library of epigenetic scars earned through decades of viral run-ins, bacterial skirmishes, and environmental stress.

My research on the Dilution-Excision Hypothesis suggests that as cells enlarge and age, they lose their grip on where repair factors are supposed to go. But there’s a catch: the aging cell compensates by clamping down on specific spots—like Endogenous Retroviruses (ERVs)—to keep the genome from rattling itself apart. If we force these cells back to a "youthful" state, we aren't just fixing them; we’re inducing molecular amnesia.

I worry we’re building a "rejuvenated" population with the physical stamina of a thirty-year-old but the immune vulnerability of a newborn. Picture a 70-year-old whose "new" T-cells have forgotten the specific methylation patterns needed to keep a dormant shingles virus or latent Epstein-Barr infection in check. We might be swapping out slow, chronic senescence for sudden, lethal infections.

Right now, we’re optimizing for how things look on the surface—better skin, faster walking, lower inflammation—without measuring the biological archive.

We need collaborators in comparative immunogenomics to help us figure out which epigenetic marks are just "rust" and which ones are "armor." Most funding is obsessed with resetting the clock, but we should be funding research that tells us which hands of that clock are actually holding the door shut against the viruses inside us. If we scrub away the scars, do we lose the shield too?